Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Usmani, Saad
Item TypeName
Concept Immunotherapy, Adoptive
Academic Article CAR T-cell therapy for multiple myeloma: state of the art and prospects.
Academic Article Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Academic Article Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Academic Article Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.
Academic Article Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma.
Academic Article BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
Academic Article Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Academic Article Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
Academic Article GPRC5D-Targeted CAR T Cells for Myeloma.
Academic Article Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Academic Article How Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?
Academic Article The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies.
Academic Article Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma.
Search Criteria
  • Immunotherapy Adoptive